CFOO China Foods Holdings Ltd.
Medicinal Chemicals & Botanical Products · OTC · SEC CIK 1310630 · Fiscal year ends 12/31
Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY-46.6%
TTM net income YoY33.6%
TTM EPS YoY0.0%
Revenue 3-yr CAGR-3.9%
Net income 3-yr CAGR—
Margins
Gross margin7.9%
Operating margin-173.9%
Net margin-173.8%
FCF margin—
EBITDA margin-170.1%
Returns
ROE—
ROA-114.1%
ROIC (approx.)—
Asset turnover0.66x
Leverage & solvency
Liabilities / assets756.1%
Debt / equity—
Current ratio0.11x
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.09x
Accruals ratio10.3%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $327,871 | $233,339 | $158,475 | $354,096 | $361,116 |
| Cost of revenue | $297,909 | $179,466 | $94,331 | $243,034 | $121,690 |
| Gross profit | $29,962 | $53,873 | $64,144 | $111,062 | $239,426 |
| SG&A expense | $423,644 | $502,654 | $465,234 | $500,807 | $690,780 |
| Operating income | -$398,923 | -$455,637 | -$404,637 | -$392,733 | -$456,430 |
| Pretax income | -$398,672 | -$454,735 | -$403,700 | -$353,250 | -$448,738 |
| Income tax | — | $836 | — | $828 | $6,671 |
| Net income | -$398,672 | -$455,571 | -$403,700 | -$354,078 | -$455,409 |
| EBITDA | -$391,934 | -$453,869 | -$362,247 | -$327,568 | -$365,469 |
| EPS (basic) | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| EPS (diluted) | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| Weighted avg. shares (diluted) | 20.25M | 20.25M | 20.25M | 20.25M | 20.25M |
| Banking | |||||
| Net interest income | $45 | $329 | $594 | $190 | $1,277 |
| Balance sheet | |||||
| Cash & equivalents | $9,893 | $39,192 | $174,877 | $381,709 | $609,434 |
| Receivables | — | — | $38,831 | $5,120 | — |
| Inventory | $39,255 | $54,943 | $48,282 | $138,582 | $327,551 |
| Current assets | $162,943 | $398,686 | $349,603 | $600,224 | $1.09M |
| PP&E, net | $27,860 | $34,264 | $12,981 | $55,495 | $132,604 |
| Intangibles | $1,662 | $2,055 | $2,597 | $3,148 | $3,947 |
| Total assets | $212,890 | $435,005 | $365,181 | $679,208 | $1.57M |
| Current liabilities | $1.48M | $1.29M | $755,996 | $661,779 | $925,540 |
| Total liabilities | $1.49M | $1.29M | $755,996 | $661,779 | $1.17M |
| Shareholders' equity | -$1.28M | -$850,807 | -$390,815 | $17,429 | $400,701 |
| Shares outstanding | 20.25M | 20.25M | 20.25M | 20.25M | 20.25M |
| Cash flow statement | |||||
| Operating cash flow | -$389,251 | -$353,812 | -$316,916 | -$171,598 | -$438,620 |
| Capital expenditure | — | $23,454 | $746 | — | $27,358 |
| Free cash flow | — | -$377,266 | -$317,662 | — | -$465,978 |
| Investing cash flow | — | -$23,454 | -$746 | $22,930 | -$27,358 |
| Financing cash flow | $388,605 | $245,524 | $114,270 | -$52,688 | $50,319 |
| Depreciation & amortization | $6,989 | $1,768 | $42,390 | $65,165 | $90,961 |
Free plan shows the latest 5 periods; Pro shows all 23 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.